A detailed history of Quest Partners LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Quest Partners LLC holds 18,827 shares of COLL stock, worth $788,098. This represents 0.08% of its overall portfolio holdings.

Number of Shares
18,827
Previous 6,583 185.99%
Holding current value
$788,098
Previous $256 Million 137.22%
% of portfolio
0.08%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$31.36 - $39.99 $383,971 - $489,637
12,244 Added 185.99%
18,827 $606 Million
Q1 2024

May 09, 2024

BUY
$31.23 - $40.91 $205,587 - $269,310
6,583 New
6,583 $256 Million

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.43B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.